392 related articles for article (PubMed ID: 21355084)
21. The National Institutes of Health criteria for classification and scoring of chronic graft versus host disease: long-term follow-up of a single center series.
Tecchio C; Mosna F; Andreini A; Paoli L; Di Bella R; de Sabata D; Sorio M; Pizzolo G; Benedetti F
Leuk Lymphoma; 2013 May; 54(5):1020-7. PubMed ID: 23035648
[TBL] [Abstract][Full Text] [Related]
22. A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-Disease.
Patel SS; Hong S; Rybicki L; Farlow S; Dabney J; Kalaycio M; Sobecks R; Majhail NS; Hamilton BK
Transplant Cell Ther; 2023 Jul; 29(7):465.e1-465.e7. PubMed ID: 37003415
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.
Lee Sk; Cook EF; Soiffer R; Antin JH
Biol Blood Marrow Transplant; 2002; 8(8):444-52. PubMed ID: 12234170
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.
Palmer J; Williams K; Inamoto Y; Chai X; Martin PJ; Tomas LS; Cutler C; Weisdorf D; Kurland BF; Carpenter PA; Pidala J; Pavletic SZ; Wood W; Jacobsohn D; Arai S; Arora M; Jagasia M; Vogelsang GB; Lee SJ
Biol Blood Marrow Transplant; 2014 Mar; 20(3):337-44. PubMed ID: 24315845
[TBL] [Abstract][Full Text] [Related]
25. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z
Front Immunol; 2019; 10():1879. PubMed ID: 31507582
[TBL] [Abstract][Full Text] [Related]
26. Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center.
Herzberg PY; Lee SJ; Heussner P; Mumm FH; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix HT; Freund M; Holler E; Wolff D
Bone Marrow Transplant; 2013 Jan; 48(1):129-34. PubMed ID: 22609882
[TBL] [Abstract][Full Text] [Related]
27. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.
Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ;
Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease.
Baumrin E; Baker LX; Byrne M; Martin PJ; Flowers ME; Onstad L; El Jurdi N; Chen H; Beeghly-Fadiel A; Lee SJ; Tkaczyk ER
JAMA Dermatol; 2023 Apr; 159(4):393-402. PubMed ID: 36884224
[TBL] [Abstract][Full Text] [Related]
29. Frailty in Patients with Chronic Graft-versus-Host Disease.
Rashid N; Arora M; Jurdi NE; Onstad L; Pidala JA; Flowers ME; Lee SJ
Transplant Cell Ther; 2023 Jun; 29(6):367-374. PubMed ID: 36921916
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of NIH consensus criteria for chronic graft-versus-host disease.
Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC
Leukemia; 2009 Jan; 23(1):78-84. PubMed ID: 18830253
[TBL] [Abstract][Full Text] [Related]
31. Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health.
Wolff D; Herzberg PY; Herrmann A; Pavletic SZ; Heussner P; Mumm F; Höfer C; Hilgendorf I; Hemmati PG; Holler E; Greinix H; Mitchell SA
Bone Marrow Transplant; 2021 Jan; 56(1):243-256. PubMed ID: 32737446
[TBL] [Abstract][Full Text] [Related]
32. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study.
Bonifazi F; Solano C; Wolschke C; Sessa M; Patriarca F; Zallio F; Nagler A; Selleri C; Risitano AM; Messina G; Bethge W; Herrera P; Sureda A; Carella AM; Cimminiello M; Guidi S; Finke J; Sorasio R; Ferra C; Sierra J; Russo D; Benedetti E; Milone G; Benedetti F; Heinzelmann M; Pastore D; Jurado M; Terruzzi E; Narni F; Völp A; Ayuk F; Ruutu T; Kröger N
Lancet Haematol; 2019 Feb; 6(2):e89-e99. PubMed ID: 30709437
[TBL] [Abstract][Full Text] [Related]
33. Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell Transplantation.
Rotz SJ; Yi JC; Hamilton BK; Wei W; Preussler JM; Cerny J; Deol A; Jim H; Khera N; Hahn T; Hashmi SK; Holtan S; Jaglowski SM; Loren AW; McGuirk J; Reynolds J; Saber W; Savani BN; Stiff P; Uberti J; Wingard JR; Wood WA; Baker KS; Majhail NS; Syrjala KL
Transplant Cell Ther; 2022 Oct; 28(10):701.e1-701.e7. PubMed ID: 35872304
[TBL] [Abstract][Full Text] [Related]
34. Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD.
Kim DY; Lee JH; Lee JH; Kim SH; Lim SN; Kim SD; Choi Y; Lee YS; Kang YA; Kang SI; Seol M; Ryu SG; Lee KH
Bone Marrow Transplant; 2010 Jul; 45(7):1174-80. PubMed ID: 19915630
[TBL] [Abstract][Full Text] [Related]
35. Symptoms, Cytokines, and Quality of Life in Patients Diagnosed with Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.
Lynch Kelly D; Lyon DE; Ameringer SA; Elswick RK
Oncol Nurs Forum; 2015 May; 42(3):265-75. PubMed ID: 25901378
[TBL] [Abstract][Full Text] [Related]
36. Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD).
Elad S; Zeevi I; Or R; Resnick IB; Dray L; Shapira MY
Biol Blood Marrow Transplant; 2010 Jan; 16(1):62-9. PubMed ID: 19733252
[TBL] [Abstract][Full Text] [Related]
37. Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes.
Hamilton BK; Rybicki L; Arai S; Arora M; Cutler CS; Flowers MED; Jagasia M; Martin PJ; Palmer J; Pidala J; Majhail NS; Lee SJ; Khera N
Biol Blood Marrow Transplant; 2018 Feb; 24(2):393-399. PubMed ID: 29032275
[TBL] [Abstract][Full Text] [Related]
38. Validation of NIH consensus criteria for diagnosis and severity-grading of chronic graft-versus-host disease.
Aisa Y; Mori T; Kato J; Yamane A; Kohashi S; Kikuchi T; Okamoto S
Int J Hematol; 2013 Feb; 97(2):263-71. PubMed ID: 23371545
[TBL] [Abstract][Full Text] [Related]
39. NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD.
Curtis LM; Grkovic L; Mitchell SA; Steinberg SM; Cowen EW; Datiles MB; Mays J; Bassim C; Joe G; Comis LE; Berger A; Avila D; Taylor T; Pulanic D; Cole K; Baruffaldi J; Fowler DH; Gress RE; Pavletic SZ
Bone Marrow Transplant; 2014 Dec; 49(12):1513-20. PubMed ID: 25153693
[TBL] [Abstract][Full Text] [Related]
40. Vision-Related Quality of Life in Patients with Ocular Graft-versus-Host Disease.
Saboo US; Amparo F; Abud TB; Schaumberg DA; Dana R
Ophthalmology; 2015 Aug; 122(8):1669-74. PubMed ID: 26001816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
